A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses (Happy Nurse Project): study protocol for a randomized controlled trial.
Study Design
- Çalışma Türü
- Randomized Controlled Trial
- Örneklem Büyüklüğü
- 120
- Süre
- 52 weeks
- Müdahale
- A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses (Happy Nurse Project): study protocol for a randomized contro omega-3 fatty acids: 1200 mg/day EPA + 600 mg/day DHA for 90 days
- Karşılaştırıcı
- Placebo
- Etki Yönü
- Positive
- Yanlılık Riski
- Low
Abstract
BACKGROUND: It is reported that nursing is one of the most vulnerable jobs for developing depression. While they may not be clinically diagnosed as depressed, nurses often suffer from depression and anxiety symptoms, which can lead to a low level of patient care. However, there is no rigorous evidence base for determining an effective prevention strategy for these symptoms in nurses. After reviewing previous literature, we chose a strategy of treatment with omega-3 fatty acids and a mindfulness-based stress management program for this purpose. We aim to explore the effectiveness of these intervention options for junior nurses working in hospital wards in Japan. METHODS/DESIGN: A factorial-design multi-center randomized trial is currently being conducted. A total of 120 nurses without a managerial position, who work for general hospitals and gave informed consent, have been randomly allocated to a stress management program or psychoeducation using a leaflet, and to omega-3 fatty acids or identical placebo pills. The stress management program has been developed according to mindfulness cognitive therapy and consists of four 30-minute individual sessions conducted using a detailed manual. These sessions are conducted by nurses with a managerial position. Participants allocated to the omega-3 fatty acid groups are provided with 1,200 mg/day of eicosapentaenoic acid and 600 mg/day of docosahexaenoic acid for 90 days. The primary outcome is the change in the total score of the Hospital Anxiety and Depression Scale (HADS), determined by a blinded rater via the telephone at week 26. Secondary outcomes include the change in HADS score at 13 and 52 weeks; presence of a major depressive episode; severity of depression, anxiety, insomnia, burnout, and presenteeism; utility scores and adverse events at 13, 26 and 52 weeks. DISCUSSION: An effective preventive intervention may not only lead to the maintenance of a healthy mental state in nurses, but also to better quality of care for inpatients. This paper outlines the background and methods of a randomized trial that evaluates the possible additive value of omega-3 fatty acids and a mindfulness-based stress management program for reducing depression in nurses. TRIAL REGISTRATION: Clinicaltrials.gov: NCT02151162 (registered on 27 May 2014).
Full Text
Figures
Tables
Table 1
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
| Kyoto University | HADS assessed through telephone | x | x | x | x | |
| Allocation guessed by raters | x | x | x | |||
| CRC | Informed consent, registration to EDC, information about allocated group | x | ||||
| Socio-demographic variables (such as age, academic status, marital status and partners) | x | |||||
| Concentrations of omega-3 fatty acids in membrane of RBC, oxidative stress, and antioxidant status | x | x | ||||
| (2 hospitals) | (2 hospitals) | |||||
| Participants’ input through EDC | PHQ-9 | x | x | x | x | |
| GAD-7 | x | x | x | x | ||
| ISI | x | x | x | x | ||
| MBI | x | x | x | x | ||
| BSI | x | x | x | x | x | |
| HPQ | x | x | x | x | ||
| EQ-5D | x | x | x | x | ||
| Numbers of incidents and accidents | x | x | x | x | ||
| Numbers of visits to clinics | x | x | x | x | ||
| Numbers of absent days due to any reason | x | x | x | x | ||
| History of taking psychotropic drugs | x | x | x | x | ||
| Adverse events | x | x | x | x |
References
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
Used In Evidence Reviews
Similar Papers
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
Annual review of pharmacology and toxicology · 2016
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
Molecular medicine reports · 2010
Chamomile: A herbal medicine of the past with bright future.
Journal of pineal research · 2012
Melatonin and its analogs in insomnia and depression.
Journal of psychopharmacology (Oxford, England) · 2005
Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability.
Sleep medicine reviews · 2015